Tenet Healthcare Corp Receivables Turnover Ratio (THC), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Tenet Healthcare Corp  (NYSE: THC)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Tenet Healthcare Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Tenet Healthcare Corp's ability to collect accounts receivable sequentially worsen to 8.06, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Tenet Healthcare's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 45 days, from 44 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 153 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1500, from overall ranking in the first quarter 2026 at 1782.

What is Receivable Turnover Ratio?
What is Tenet Healthcare Corp Selling?


What is Receivable Turnover Ratio?





THC Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change 14.8 % -0.53 % 9.98 % -3.08 % -10.08 %
Y / Y Revenue Change 6.77 % 2.78 % 8.97 % 3.26 % 3.29 %
Receivable Turnover Ratio (TTM) 8.06 8.22 8.15 8.17 8.05
THC's Total Ranking # 1500 # 1782 # 1616 # 1655 # 1763
Accounts Receivable average collection period days 45 44 45 45 45
Seq. Receivable Change 11.63 % -6.6 % 10.76 % -0.59 % -3.28 %
Seq. Revenue Change 4.84 % -2.88 % 4.5 % 0.34 % 0.92 %


Receivable Turnover Company Ranking
Within: No.
Healthcare Facilities Industry # 19
Healthcare Sector # 154
Overall Market # 1500

Receivable Turnover Ratio Statistics
High Average Low
15.19 7.49 5.97
(Dec 31 2013)   (Sep. 30, 2006)




  News about Tenet Healthcare Corp Receivables Turnover Ratios

Tenet Healthcare Strong Earnings Growth Anticipated as Shares Trail Market Performance

In the upcoming financial report from Tenet Healthcare (THC), Wall Street eagerly anticipates the company s earnings growth. Tenet Healthcare has demonstrated the right combination of factors that make it likely to outperform expectations. This article explores the recent trends, analyst perspectives, and the company s market performance to provide a comprehensive analysis of Tenet Healthcare s potential.Short Interest Decreases, Signaling Potential Rise in Stock:Recent data reveals a decline in the percentage of shares being sold short for Tenet Healthcare. This decrease in short interest suggests a positive sentiment surrounding the stock and a potential rise in its value. While this indicator doesn t guarantee stock appreciation, it provides investors with an encouraging sign for the company s future.




Financial Statements
Tenet Healthcare's Accounts Receivable $ 2,908 Millions Visit THC's Balance sheet
Tenet Healthcare's Sales TTM $ 21,812 Millions Visit THC's Income Statement
Sources of THC's Revenues Visit THC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
THC's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
THC's Growth Rates THC's Roa THC's Inventory Turnover Ratio THC's Dividend Comparisons
THC's Profitability Ratios THC's Roi THC's Asset Turnover Ratio THC's Dividend Growth
THC's Valuation Ratios THC's Roe THC's Financial Strength Ratios THC's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Lineage Cell Therapeutics Inc   20.02 $ 13.083  Millions$ 0.654  Millions
Hims and Hers Health Inc   19.65 $ 2,578.494  Millions$ 131.228  Millions
Neuraxis Inc   18.95 $ 5.316  Millions$ 0.281  Millions
China Pharma Holdings Inc  18.55 $ 3.914  Millions$ 0.211  Millions
Bausch Health Companies Inc   18.42 $ 10,853.000  Millions$ 589.250  Millions
Arvinas Inc   17.26 $ 316.700  Millions$ 18.350  Millions
Nrx Pharmaceuticals Inc   17.25 $ 3.394  Millions$ 0.197  Millions
Polomar Health Services, Inc.  17.19 $ 3.172  Millions$ 0.185  Millions
Escalon Medical Corp   16.86 $ 12.736  Millions$ 0.756  Millions
Anika Therapeutics Inc   16.70 $ 121.370  Millions$ 7.266  Millions
Lifemd Inc   16.48 $ 163.363  Millions$ 9.915  Millions
Longeveron Inc   16.43 $ 1.187  Millions$ 0.072  Millions
Bioage Labs Inc   15.82 $ 10.355  Millions$ 0.655  Millions
Vaxart Inc   15.09 $ 243.064  Millions$ 16.108  Millions
Medicinova Inc   15.02 $ 0.920  Millions$ 0.061  Millions
Voyager Therapeutics Inc   14.71 $ 34.459  Millions$ 2.343  Millions
Halozyme Therapeutics Inc   14.68 $ 1,663.738  Millions$ 113.332  Millions
Nexgel Inc   14.52 $ 11.810  Millions$ 0.813  Millions
Skinhealth Systems Inc   14.42 $ 289.224  Millions$ 20.051  Millions
Lftd Partners Inc   14.13 $ 35.335  Millions$ 2.500  Millions
Talkspace Inc   14.09 $ 246.631  Millions$ 17.506  Millions
Lifestance Health Group Inc   14.07 $ 1,584.834  Millions$ 112.665  Millions
10x Genomics Inc   13.90 $ 616.566  Millions$ 44.342  Millions
Amneal Pharmaceuticals Inc   13.90 $ 3,117.474  Millions$ 224.342  Millions
Ataibeckley Inc   13.83 $ 4.473  Millions$ 0.324  Millions
Corcept Therapeutics Inc  13.54 $ 830.813  Millions$ 61.352  Millions
Rosecliff Acquisition Corp I  13.43 $ 16.467  Millions$ 1.226  Millions
Precipio inc   13.25 $ 27.198  Millions$ 2.052  Millions
Chemed Corporation  12.94 $ 2,595.001  Millions$ 200.565  Millions
Qhslab Inc   12.77 $ 3.017  Millions$ 0.236  Millions

Date modified: 2026-10-05T11:03:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.